Request Sample Inquiry
Buprenorphine Hydrochloride Market

Buprenorphine Hydrochloride Market

Buprenorphine Hydrochloride Market Global Industry Assessment & Forecast

# Pages:


Base Year:


Nov - 2021


Report Code:


Segments Covered
  • By Type Tablets, Injection
  • By Application Analgesic, Opioid Antagonist
Forecast YearsForecast Years: 2021 - 2028
Historical YearsHistorical Years: 2016 - 2020
Revenue 2021Revenue 2021: 5.05 Billion
Revenue 2028Revenue 2028: 9.49 Billion
Revenue CAGRRevenue CAGR (2021 - 2028): 8.2
Fastest Growing Region Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Frequently Asked Question
  • The global Buprenorphine Hydrochloride valued at 5.05 Billion in 2020 and is expected to reach 9.49 Billion in 2028 growing at a CAGR of 8.2%.

  • The prominent players in the market are Resonance-labs, UnichemlabsNoramco, Siegfried, Faranshimi, Johnson Matthey, Rusan Pharma, Mallinckrodt, Sanofi, Sun Pharma, Mocind, Sinopharm, Arevipharma..

  • The market is project to grow at a CAGR of 8.2% between 2021 and 2028.

  • The driving factors of the Buprenorphine Hydrochloride include

    • The increasing opioid addiction cases are driving the growth of the buprenorphine hydrochloride market within estimated timeframe. With this, the number of reported cases of opioid addiction is increasing due to the high availability and low cost of opioids that is also likely to support the growth of the market.
    • The increasing innovations and development by government in healthcare sector is expected to hinder the growth of the market in the years to come.

  • North America was the leading regional segment of the Buprenorphine Hydrochloride in 2020.